Pre-Cancerous Dysplasia

2

Review clinical trials related to Pre-Cancerous Dysplasia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

This is a phase II double blind, placebo-controlled, randomized study of Artesunate vaginal inserts for the treatment of women who have cervical high grade intraepithelial neoplasia (CIN2/3).

Participants needed: 78
Trial details
Phase: Phase 2Age: 25-100Biological sex: FemaleType: InterventionalSponsor: Frantz Viral Therapeutics, LLCUpdated: Oct 2, 2025Locations: 7
Eligibility criteria

Adult females age ≥ 25 years [+5]

Pregnant and nursing women [+6]

Status: Recruiting

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

This is a phase II double-blind, placebo-controlled study of artesunate ointment for the treatment of HPV-associated vulvar HSIL (usual type vulvar intraepithelial neoplasia 2/3).

Participants needed: 27
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: Frantz Viral Therapeutics, LLCUpdated: Aug 14, 2025Locations: 5
Eligibility criteria

Adult women age ≥ 18 years [+10]

Pregnant and nursing women [+10]